Somatuline® Autogel® is indicated for1:
The Highly Specialised Drugs (HSD) Community Access program allows healthcare professionals to provide patients with Carcinoid Syndrome or Acromegaly access to Somatuline® Autogel® in their local community. For suitable patients, physicians can prescribe Somatuline® Autogel® using the S100 HSD Community Access code, enabling patients to fill their prescription at their local community pharmacy. Please refer to PBS schedule for full details.6
This tailored solution provides flexibility for patients in both access and administration of Somatuline® Autogel®. For some, Community Access may also facilitate self-injection as an appropriate form of administration.1,5-7
HSD Community Access and S100 Public are streamlined authorities which means no phone calls are required to issue scripts, freeing up more time to spend with your patients.1,5,6
IGF1: Insulin-like Growth Factor 1; GEPNETS: Gastroenteropancreatic neuroendocrine tumours; SSA: somatostatin analogue; SC: subcutaneous; HSD: Highly Specialised Drugs; PBS: Pharmaceutical Benefits Scheme; ENETS: European Neuroendocrine Tumor Society; NCCN: National Comprehensive Cancer Network; NANETS: North American Neuroendocrine Tumor Society; NETS: Neuroendocrine Tumours; ENSA: Endocrine Nurses’ Society of Australasia.